|
|
|
| An isolator is an airtight barrier that encloses a sterile manufacturing line, creating a tightly controlled environment accessed only through sealed glove ports. By precisely managing temperature, pressure, airflow, and humidity while eliminating direct human contact, isolators deliver superior sterility assurance. Industry guidance, including Annex 1, strongly recommends isolators as part of a robust Contamination Control Strategy. Learn how isolator technology can strengthen your aseptic fill-finish operations. |
|
|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | A good CDMO – differentiated from a not-as-good CDMO – dialogues productively with customers, and a great starting point is when discussing development plans that should then lead to manufacturing opportunities. What should these conversations entail? Outsourcing pro David Grote speaks to Chief Editor Louis Garguilo on his "discussion philosophy." | |
|
|
January 2026 — CDMO Opportunities And Threats Report | By GlobalData | Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Work With An In-Country Depot For Efficiency And Compliance | Article | By Soudeh Tehrani, Lisa Lemelin, and Anh-Thu Le, Ropack Pharma Solutions | If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials. |
|
|
| Harness High-Quality PBPK Modeling To Enhance Clinical Readiness | Article | By Deanna Mudie Ph.D. and John DiBella, Lonza | Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties. |
|
|
|
|
Minitabs Technology | Adare Pharma Solutions | Discover a multi-particulate system that provides unparalleled flexibility in dosage forms, which allows you to create customized release profiles, precise dosing, and a wide range of delivery options. |
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
| CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
